Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T

In the continuing search for a non-invasive imaging technique that can reliably differentiate prostate cancer from benign prostatic hyperplasia and healthy tissue, proton MR spectroscopic imaging (MRSI) of the human prostate is of prime interest, since prostate cancer tissue is characterized by reduced levels of citrate and increased levels of choline (1-2), which both are detectable in vivo with 1H-MRSI. Increasing the magnetic field strength from 1.5T to 3T may have substantial benefits fo